<DOC>
	<DOCNO>NCT02309762</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics , immunogenicity single-ascending IV dose FB825</brief_summary>
	<brief_title>A Study Investigate Safety , Tolerability , Pharmacokinetics , Immunogenicity FB825 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . The subject male female 18 55 year age , inclusive . 2 . All female subject must negative serum pregnancy test screen Day −1 . 3 . The subject body weight ≥50 kg screen body mass index 18 30 kg/m2 , inclusive . 4 . The subject good health condition base upon result medical history , physical examination , vital sign , laboratory profile ECG . 5 . The subject negative urine drug screen alcohol , cotinine . 1 . Female subject pregnant lactating . 2 . The subject past history heart arrhythmia . 3 . The subject history clinically significant disease . 4 . The subject history previous anaphylactic reaction . 5 . Use prescribed medication within 6 month Day −1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>